ConductScience.org, home

Paper22958482

Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.

Bergmann-Leitner ES and 3 others. Malar J, 2012. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine. Papers, record 22958482. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22958482

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of pre-existing MSP1(42)-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine.
PubMed
Journal
Malar J
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.33
iCite
Revised in PubMed
2021-10-21
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bergmann-Leitner ESElke S
2Duncan EHElizabeth H
3Mease RMRyan M
4Angov EEvelina

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MalariaMajor topic
Malaria VaccinesMajor topic
Merozoite Surface Protein 1Major topic
Animals
Antibodies, Protozoan
Enzyme-Linked Immunosorbent Assay
Enzyme-Linked Immunospot Assay
Immunoglobulin G
Mice
Plasmodium falciparum
T-Lymphocytes
Vaccines, Subunit
Vaccines, Synthetic

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115618165
The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.
Infect Immun2005https://conductscience.org/library/papers/15618165PubMed
218958285Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults.PLoS One2008https://conductscience.org/library/papers/18958285PubMed
319050299Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.J Immunol2008https://conductscience.org/library/papers/19050299PubMed
410339410Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1.J Mol Biol1999https://conductscience.org/library/papers/10339410PubMed
58529111Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.Mol Med1995https://conductscience.org/library/papers/8529111PubMed
68723921Improved technique for the preparation of water-in-oil emulsions containing protein antigens.Biotechniques1996https://conductscience.org/library/papers/8723921PubMed
77602100Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.J Immunol1995https://conductscience.org/library/papers/7602100PubMed
816356603Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.Vaccine2006https://conductscience.org/library/papers/16356603PubMed
99497045Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.Mol Biochem Parasitol1997https://conductscience.org/library/papers/9497045PubMed
1021277408Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized.Vaccine2011https://conductscience.org/library/papers/21277408PubMed
117909653Immunity to erythrocytic stages of malarial parasites.Am J Trop Med Hyg1994https://conductscience.org/library/papers/7909653PubMed
1316619284Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming.Eur J Immunol2006https://conductscience.org/library/papers/16619284PubMed
1420696832Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.Infect Immun2010https://conductscience.org/library/papers/20696832PubMed
1517124530Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.PLoS Clin Trials2006https://conductscience.org/library/papers/17124530PubMed
1618337345Miniaturization of a high-throughput pLDH-based Plasmodium falciparum growth inhibition assay for small volume samples from preclinical and clinical vaccine trials.Am J Trop Med Hyg2008https://conductscience.org/library/papers/18337345PubMed
179095224Regulation of interleukin-12 signalling during T helper phenotype development.Adv Exp Med Biol1996https://conductscience.org/library/papers/9095224PubMed
1822076863Histidine affinity tags affect MSP1(42) structural stability and immunodominance in mice.Biotechnol J2012https://conductscience.org/library/papers/22076863PubMed
1918478103Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host.PLoS One2008https://conductscience.org/library/papers/18478103PubMed
208627050Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.J Infect Dis1996https://conductscience.org/library/papers/8627050PubMed
2121916638A field trial to assess a blood-stage malaria vaccine.N Engl J Med2011https://conductscience.org/library/papers/21916638PubMed

See all 54 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
38276660Multiplex Assays for Analysis of Antibody Responses to South Asian Plasmodium falciparum and Plasmodium vivax Malaria Infections.Vaccines (Basel)2023https://conductscience.org/library/papers/38276660PubMed
35656326Rare Alleles and Signatures of Selection on the Immunodominant Domains of Pfs230 and Pfs48/45 in Malaria Parasites From Western Kenya.Front Genet2022https://conductscience.org/library/papers/35656326PubMed
35390042Signatures of selection and drivers for novel mutation on transmission-blocking vaccine candidate Pfs25 gene in western Kenya.PLoS One2022https://conductscience.org/library/papers/35390042PubMed
28543553Enhanced acquired antibodies to a chimeric Plasmodium falciparum antigen; UB05-09 is associated with protective immunity against malaria.Parasite Immunol2017https://conductscience.org/library/papers/28543553PubMed
26344620Adjuvants in the Driver's Seat: How Magnitude, Type, Fine Specificity and Longevity of Immune Responses Are Driven by Distinct Classes of Immune Potentiators.Vaccines (Basel)2014https://conductscience.org/library/papers/26344620PubMed
24741614Genetic diversity of MSP1 Block 2 of Plasmodium vivax isolates from Manaus (central Brazilian Amazon).J Immunol Res2014https://conductscience.org/library/papers/24741614PubMed
24187566N-terminal Plasmodium vivax merozoite surface protein-1, a potential subunit for malaria vivax vaccine.Clin Dev Immunol2013https://conductscience.org/library/papers/24187566PubMed
24098747Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines.PLoS One2013https://conductscience.org/library/papers/24098747PubMed
23977965High levels of IgG3 anti ICB2-5 in Plasmodium vivax-infected individuals who did not develop symptoms.Malar J2013https://conductscience.org/library/papers/23977965PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CAMP820PubTator's text mininghttps://conductscience.org/library/genes/820NCBI Gene
EGF1950PubTator's text mininghttps://conductscience.org/library/genes/1950NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL23A51561PubTator's text mininghttps://conductscience.org/library/genes/51561NCBI Gene
ING13621PubTator's text mininghttps://conductscience.org/library/genes/3621NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22958482

GET https://conductscience.org/api/papers/v1/22958482/references?page=2